DocGo (NASDAQ:DCGO) Announces Earnings Results, Misses Expectations By $0.06 EPS

DocGo (NASDAQ:DCGO) announced its earnings results on Monday. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.06), FiscalAI reports. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. The company had revenue of $73.43 million for the quarter, compared to analyst estimates of $77.24 million.

Here are the key takeaways from DocGo’s conference call:

• Third-quarter revenue was $73.4 million, up 4% year over year, while the adjusted EBITDA loss narrowed to $3.2 million from $7.2 million a year earlier and $6.3 million in the prior quarter.
• DocGo lowered its 2026 revenue outlook to approximately $300 million from $305 million–$310 million, while reaffirming its adjusted EBITDA loss guidance of $17 million–$22 million. Management attributed the revenue reduction partly to exiting or restructuring unprofitable business.
• Gross margin rose to 33.3% from 30.5% in the second quarter, and adjusted SG&A declined to $28.7 million. Management cited cost cuts and AI-enabled outreach, which it said reduced cost per booking by more than 50%.
• Cash was $19.1 million at quarter-end, down from $25.2 million at the end of Q2. A $12.5 million term-loan tranche closed after quarter-end, with additional funding dependent on the Hicuity transaction and revenue conditions; the company is also pursuing collection of about $19 million in receivables.
• CEO Lee Bienstock plans to transition out once a successor is appointed and expects to remain through at least March 31, 2027. Management did not provide formal 2027 guidance, but said it anticipates revenue growth and positive adjusted EBITDA for the year.

DocGo Trading Up 2.8%

Shares of DCGO stock traded up $0.01 on Monday, hitting $0.25. 603,175 shares of the stock were exchanged, compared to its average volume of 850,321. The business has a 50-day moving average of $0.33 and a 200 day moving average of $0.56. The firm has a market capitalization of $24.91 million, a P/E ratio of -0.13 and a beta of 1.03. DocGo has a fifty-two week low of $0.21 and a fifty-two week high of $1.17.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 price objective on shares of DocGo in a research report on Tuesday, August 18th. Needham & Company LLC restated a “buy” rating on shares of DocGo in a report on Wednesday, September 30th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research report on Monday, September 14th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, DocGo has an average rating of “Hold” and an average price target of $2.17.

DocGo Company Profile

DocGo Inc (NASDAQ:DCGO) is a healthcare services company that delivers medical care and related support outside traditional healthcare facilities. Its platform combines mobile medical services, technology and logistics to help healthcare providers, government agencies and other organizations improve access to care.

The company provides mobile health services that can include in-home and community-based clinical care, preventive services, diagnostic testing, vaccinations and care coordination.